- Home
- DTST vs COEP Comparison
DTST vs COEP Comparison
Compare DTST & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- COEP
- Stock Information
- Founded
- DTST 2001
- COEP 2017
- Country
- DTST United States
- COEP United States
- Employees
- DTST N/A
- COEP N/A
- Industry
- DTST EDP Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTST Technology
- COEP Health Care
- Exchange
- DTST Nasdaq
- COEP Nasdaq
- Market Cap
- DTST 28.2M
- COEP 27.4M
- IPO Year
- DTST N/A
- COEP N/A
- Fundamental
- Price
- DTST $3.35
- COEP $9.81
- Analyst Decision
- DTST
- COEP
- Analyst Count
- DTST 0
- COEP 0
- Target Price
- DTST N/A
- COEP N/A
- AVG Volume (30 Days)
- DTST 24.9K
- COEP 37.8K
- Earning Date
- DTST 08-13-2025
- COEP 08-15-2025
- Dividend Yield
- DTST N/A
- COEP N/A
- EPS Growth
- DTST N/A
- COEP N/A
- EPS
- DTST 0.02
- COEP N/A
- Revenue
- DTST $25,219,312.00
- COEP $62,874.00
- Revenue This Year
- DTST $12.57
- COEP N/A
- Revenue Next Year
- DTST $9.29
- COEP N/A
- P/E Ratio
- DTST $142.05
- COEP N/A
- Revenue Growth
- DTST N/A
- COEP N/A
- 52 Week Low
- DTST $2.93
- COEP $2.31
- 52 Week High
- DTST $6.53
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- DTST 40.78
- COEP 65.80
- Support Level
- DTST $3.33
- COEP $7.25
- Resistance Level
- DTST $3.56
- COEP $9.90
- Average True Range (ATR)
- DTST 0.13
- COEP 0.57
- MACD
- DTST 0.00
- COEP 0.30
- Stochastic Oscillator
- DTST 6.25
- COEP 100.00
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.